Filing Analysis
HealthLynked Corp. issued ten senior secured convertible promissory notes totaling $900,000 and a warrant to purchase 9,259,258 shares of common stock to the Mary S. Dent Gifting Trust. The transaction is a related-party deal as the Purchaser is controlled by the Company's CEO and Chairman, Dr. Michael Dent.
🚩 Red Flags
- Related-party transaction: The purchaser is controlled by the CEO and Chairman, Dr. Michael Dent.
- Highly dilutive financing: Issuance of over 9 million warrants at a very low conversion price ($0.0486).
- Senior secured debt: The notes are backed by a first priority lien on all company assets, placing the lender (CEO's trust) ahead of other creditors.
- High interest rate penalty: Interest jumps from 12% to 18% upon default.
📋 Key Facts
- Issued $900,000 in aggregate principal amount via ten senior secured convertible promissory notes on September 19, 2024.
- Net proceeds to the company were $855,000 after a 5% original issue discount.
- The Notes carry a 12% annual interest rate, increasing to 18% in the event of default.
- Notes are convertible at a price of $0.0486 per share; Warrant exercise price is also $0.0486 per share.
- Warrant allows for the purchase of 9,259,258 shares with a 10-year term.
- The Notes are secured by a first priority lien on all Company assets.
- Maturity dates for the notes range from January 2025 to March 2025.
HealthLynked Corp. announced the appointment of William Crupi as Chief Operating Officer, effective June 25, 2024. Mr. Crupi transitions from his role as Operations Manager to this executive position.
🚩 Red Flags
- None identified in this filing.
📋 Key Facts
- William Crupi appointed as Chief Operating Officer (COO) effective June 25, 2024.
- Mr. Crupi previously served as the Company's Operations Manager since April 2023.
- Base salary for the new COO is set at $120,000 per year.
- Compensation includes a 10-year stock option to purchase 300,000 shares of common stock at an exercise price of $0.081.
- Stock options vest ratably over three years: June 25, 2025; June 25, 2026; and June 25, 2027.
HealthLynked Corp. issued a $1,000,000 senior secured convertible promissory note and warrants to the Mary S. Dent Gifting Trust, an entity controlled by the Company's CEO and Chairman, Dr. Michael Dent. The transaction is secured by a first priority lien on all company assets.
🚩 Red Flags
- Related-party transaction: The purchaser is controlled by the CEO/Chairman.
- Extremely high dilution risk: Issuance of 10,000,000 warrants at a very low price ($0.0497) and convertible note functionality.
- Asset encumbrance: A first priority lien has been placed on all company assets to secure the debt to the CEO's trust.
- Penalty interest rate: Interest jumps from 12% to 18% in the event of default.
📋 Key Facts
- Issued $1,000,000 senior secured convertible promissory note to Mary S. Dent Gifting Trust (controlled by CEO/Chairman Dr. Michael Dent).
- Net proceeds of $950,000 received due to a 5% original issue discount.
- Note carries a 12% annual interest rate, increasing to 18% upon an Event of Default.
- Warrant issued for 10,000,000 shares of common stock with an exercise price of $0.0497 and a 10-year term.
- Note matures on June 3, 2025, and is subject to mandatory conversion upon a Qualified Equity Financing or at maturity.
- The Note is secured by a first priority lien on all assets of the Company.
HealthLynked Corp. announced the appointment of David Rosal as Chief Financial Officer, effective March 11, 2024. Mr. Rosal brings extensive corporate experience from Teradata and McDonald’s Corporation.
📋 Key Facts
- David Rosal appointed as CFO effective March 11, 2024.
- Base salary set at $150,000 per year.
- Eligible for the Company's 2021 Equity Incentive Plan (EIP).
- Mr. Rosal previously held senior roles at Teradata and McDonald’s Corporation.
HealthLynked Corp. announced the resignation of George O'Leary from his position as Chief Financial Officer, effective April 4, 2024. The resignation is not due to any disagreement with the company or its board.
🚩 Red Flags
- Planned departure of a key financial officer (CFO) can sometimes precede internal restructuring or reporting changes, though not indicated here.
📋 Key Facts
- George O'Leary resigned as CFO on January 5, 2024.
- The resignation becomes effective on April 4, 2024.
- Mr. O'Leary will remain on the Company's Board of Directors.
- The company explicitly states there was no disagreement regarding the resignation.